Propranolol in Conscious Spontaneously Hypertensive Rats. II. Disposition After Subcutaneous and Intracerebroventricular Administration
Overview
Authors
Affiliations
The disposition of dl-propranolol was studied in spontaneously hypertensive rats (SHR), both after subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injection of 1 mg/kg. 1. Upon s.c. injection propranolol appeared rapidly in plasma. A maximum concentration of 374 +/- 33 ng/ml (N = 10) was reached 5 min after injection. After a distribution phase with a half-life of t 1/2 alpha = 17 min propranolol was eliminated with a t 1/2 beta = 59 min. 2. Both propranolol and its metabolites were taken up rapidly into all tissues studied. Highest concentrations (10.4 +/- 1.5 micrograms/g, N = 5) were found in lungs 30 min after injection. 3. Neither propranolol nor its metabolites accumulated in any of the tissues examined. 4. Upon i.c.v. injection of propranolol, a maximal concentration of 573 +/- 47 ng/ml (N = 3) was reached in plasma already 2 min after injection. In this case t 1/2 alpha was 13 min and t 1/2 beta was 80 min. 5. Dialysis experiments indicated that propranolol is bound to plasma proteins for 92% in the concentration range of 20--100 ng/ml. With increasing concentrations binding diminishes progressively. At the highest concentration tested (345 ng/ml) only 76% was bound. It is concluded that s.c. and i.c.v. injection of an identical dose of propranolol gives a similar plasma concentration-time profile. Moreover, it is suggested that the pharmacokinetic behaviour of propranolol in SHR does not explain the delayed antihypertensive effect of this drug.
Qadri A, Cai C, Deslouches K, Siddiqui F, Aranda J, Beharry K J Ocul Pharmacol Ther. 2021; 37(2):112-130.
PMID: 33535016 PMC: 7984658. DOI: 10.1089/jop.2020.0092.
β-adrenergic modulation of discrimination learning and memory in the auditory cortex.
Schicknick H, Henschke J, Budinger E, Ohl F, Gundelfinger E, Tischmeyer W Eur J Neurosci. 2019; 50(7):3141-3163.
PMID: 31162753 PMC: 6900137. DOI: 10.1111/ejn.14480.
Spring S, Singh A, Zapata R, Chelikani P, Pezeshki A Nutrients. 2019; 11(3).
PMID: 30917593 PMC: 6470753. DOI: 10.3390/nu11030707.
Hansen N, Manahan-Vaughan D Cereb Cortex. 2014; 25(7):1889-96.
PMID: 24464942 PMC: 4459289. DOI: 10.1093/cercor/bht429.
de Leede L, De Boer A, Havermans J, Breimer D Pharm Res. 2013; 1(4):164-8.
PMID: 24277285 DOI: 10.1023/A:1016396508058.